M. Bower

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

M. Mulligan, W. Keitel, Shital M. Patel, 2015, The Journal of infectious diseases.

Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans

B. Pulendran, D. Fremont, M. McCausland, 2020, Proceedings of the National Academy of Sciences.

The Effects of Imprinting and Repeated Seasonal Influenza Vaccination on Adaptive Immunity after Influenza Vaccination

M. Mulligan, N. Rouphael, V. Karmali, 2020, Vaccines.

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

J. Mascola, R. Baric, E. Boritz, 2021, Science.

Innate, T-, and B-Cell Responses in Acute Human Zika Patients

M. Mulligan, Shital M. Patel, K. Murray, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Biphasic Zika Illness With Rash and Joint Pain

M. Mulligan, Shital M. Patel, K. Murray, 2017, Open Forum Infectious Diseases.

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.

Michael I. Jordan, Jasmine A. Berry, Mollie R. Cummins, 2023, JAMA.

Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.

F. Lessa, L. Harrison, J. Walston, 2019, Vaccine.